It is not a normal side effect of tirzepatide and should not be dismissed as an expected adjustment
In a clinical trial, people receiving the treatment are able to adhere to the prescribed regimen through support from study staff and incentives for participation, whereas in a real-world setting people may experience side effects or lose insurance coverage and stop taking their medications, Stokes says
Facilities 4.0 A star rating of 4.0 out of 5
Insulin blunts GH release
From GLP-1 receptor agonists to triple agonists, amylin combinations, and precision metabolic medicine, the 20262030 pipeline is poised to transform obesity, type 2 diabetes, MASH, cardiovascular disease, and chronic kidney disease
It's not super restrictive